Eplerenone for Eye Pressure in Healthy Adults

RD
AM
Overseen ByAlec Murphy, M.D.
Age: 18 - 65
Sex: Any
Trial Phase: Phase 1
Sponsor: University of Florida
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to determine whether eplerenone lowers eye pressure in healthy adults. Eplerenone is a medication approved by the U.S. Food and Drug Administration for other medical conditions. Researchers will compare eplerenone with placebo (a substance containing no active drug) to determine whether eplerenone affects intraocular pressure (IOP). Participants will receive both eplerenone and placebo during different study periods and will have their eye pressure measured throughout the study. Blood pressure, kidney function, and potassium levels will also be monitored for safety.

Who Is on the Research Team?

RD

Ramin Daneshvar, M.D.

Principal Investigator

University of Florida

Are You a Good Fit for This Trial?

This trial is for healthy adults who want to help researchers learn if eplerenone can lower eye pressure. Participants should not have glaucoma or high eye pressure, and must be generally healthy without serious medical conditions.

Inclusion Criteria

Systolic blood pressure >110 mmHg
Serum creatinine ≤1.3 mg/dL and serum potassium <4.3 mmol/L
Baseline intraocular pressure between 10-21 mmHg
See 2 more

Exclusion Criteria

I have kidney disease or high potassium levels.
I am taking medications that lower eye pressure.
Pregnancy or breastfeeding
See 2 more

What Are the Treatments Tested in This Trial?

Trial Overview

The study tests whether eplerenone, compared to a placebo (inactive pill), lowers eye pressure in healthy adults. Each participant will receive both treatments at different times, with regular checks of their eye pressure and overall health.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Placebo Then EplerenoneExperimental Treatment2 Interventions
Group II: Eplerenone Then PlaceboExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials
1,428
Recruited
987,000+